Polypharmacy as a risk factor in the treatment of type 2 diabetes

Diabetes Spectrum

Volumn 19, Issue 1, 2006, Pages 13-16

  Austin, Roger P ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; AMYLIN DERIVATIVE; ATENOLOL; DEXTROPROPOXYPHENE PLUS PARACETAMOL; DIGOXIN; DILTIAZEM; DIURETIC AGENT; DULOXETINE; FENOFIBRATE; FUROSEMIDE; GABAPENTIN; GLIBENCLAMIDE; HERBACEOUS AGENT; INSULIN; INSULIN DERIVATIVE; LIDOCAINE; LISINOPRIL; METFORMIN; NON PRESCRIPTION DRUG; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PIOGLITAZONE; POTASSIUM CHLORIDE; ROSIGLITAZONE; SIMVASTATIN; SULFONYLUREA DERIVATIVE; VITAMIN; WARFARIN;

AGING; BLEEDING; CLINICAL PRACTICE; CONFUSION; DIET THERAPY; DROWSINESS; DRUG APPROVAL; DRUG INDICATION; DYSLIPIDEMIA; EDEMA; HEALTH CARE COST; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; HYPERTENSION; INCOME; LIFESTYLE; MEDICAL DECISION MAKING; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PERIPHERAL NEUROPATHY; POLYPHARMACY; PRACTICE GUIDELINE; QUALITY OF LIFE; REVIEW; SEDATION; SIDE EFFECT; SOCIAL PSYCHOLOGY; SOMNOLENCE;

EID: 33344477581     PISSN: 10409165     EISSN: None     Source Type: Journal    
DOI: 10.2337/diaspect.19.1.13     Document Type: Review

References (19)

1. Cushing H: Life of Sir William Osler. Oxford, Clarendon Press, 1926
2. Monane M, Monane S, Semla T: Optimal medication use in the elderly: key to successful aging. West J Med 167:233-237, 1997
3. Lee RD: Polypharmacy: a case report and new protocol for management. J Am Board Fam Pract 11:140-144, 1998
4. Carlson JE: Perils of polypharmacy: ten steps to prudent prescribing. Geriatrics 51:26-30, 35, 1996
5. Beers MH, Ouslander JG: Risk factors in geriatric prescribing: a practical guide to avoiding problems. Drugs 37:105-112, 1989
6. Winocour PH: Effective diabetes care: a need for realistic targets. BMJ 324:1577-1580, 2002
7. Veehof L, Stewart R, Haaijer-Ruskamp F, Jong BM: The development of polypharmacy: a longitudinal study. Fam Pract 17:261-267, 2000
8. Waller DG: Rational prescribing: the principles of drug selection and assessment of efficacy. Clin Med 5:26-28, 2005
9. Redelmeier DA, Tan SH, Booth GL: The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med 338:1516-1520, 1998
10. Steinbrook R: Patients with chronic conditions: how many medications are enough? N Engl J Med 338:1541-1542, 1998
11. Rosenstock J: Management of type 2 diabetes mellitus in the elderly: special considerations. Drugs Aging 18:31-44, 2001
12. O'Connor PJ: Adding value to evidence-based clinical guidelines. JAMA 294:741-743, 2005
13. Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW: Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 294:716-724, 2005
14. Tinett ME, Bogardus ST, Agostini JV: Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med 351:2870-2874, 2004
15. Beyth RJ, Shorr RI: Epidemiology of adverse drug reactions in the elderly by drug class. Drugs Aging 14:231-239, 1999
16. Grant RW, Devita NG, Singer DE, Meigs JB: Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care 26:1408-1412, 2003
17. Osterberg L, Blaschke T: Adherence to medication. N Engl J Med 353:487-497, 2005
18. Salzman C: Medication compliance in the elderly. J Clin Psychiatry 56 (Suppl. 1):18-23, 1995
19. Aparasu RR, Sitzman SJ: Inappropriate prescribing for elderly outpatients. Am J Health Syst Pharm 56:433-439, 1999